Growth Metrics

Idexx Laboratories (IDXX) Capital Expenditures (2016 - 2026)

Idexx Laboratories has reported Capital Expenditures over the past 17 years, most recently at $29.4 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 73.37% year-over-year to $29.4 million; the TTM value through Dec 2025 reached $124.7 million, up 3.1%, while the annual FY2025 figure was $124.7 million, 3.1% up from the prior year.
  • Capital Expenditures for Q4 2025 was $29.4 million at Idexx Laboratories, down from $31.1 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $129.2 million in Q4 2022 and troughed at -$21.5 million in Q2 2022.
  • A 5-year average of $32.4 million and a median of $22.3 million in 2024 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: tumbled 797.08% in 2022 and later surged 1393.71% in 2025.
  • Year by year, Capital Expenditures stood at $104.8 million in 2021, then grew by 23.24% to $129.2 million in 2022, then tumbled by 74.8% to $32.6 million in 2023, then soared by 239.47% to $110.5 million in 2024, then crashed by 73.37% to $29.4 million in 2025.
  • Business Quant data shows Capital Expenditures for IDXX at $29.4 million in Q4 2025, $31.1 million in Q3 2025, and $53.4 million in Q2 2025.